Thomas Waggoner is a Cardiology physician affiliated with Arizona Heart Institute. OpenAlex indexes 54 publications with 793 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2404 E River Rd Ste 100
Tucson, AZ 857186521
Telephone
520-838-2148Registry record last updated 11 Jul 2016.
Clinical trials
- REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Sponsor: Medtronic Cardiovascular
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year2025116 payments$77,049openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202537 payments$21,731openpaymentsdata.cms.gov ↗
- Shockwave Medical, IncProgram year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.8%Beta blocker23.2%Carvedilol38%Metoprolol Succinate33%Metoprolol Tartrate29%Part D≥47 patientsStatin15.9%Atorvastatin Calcium68%Rosuvastatin Calcium22%Pravastatin Sodium11%Part D≥59 patients+ 12 more classes in this area
Blood & clotting
20.5%Factor Xa inhibitor10%Eliquis100%Part D≥60 patientsP2Y12 inhibitor9.8%Clopidogrel100%Part D≥67 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.6%Potassium supplement2.3%Potassium Chloride100%Part D≥20 patientsCorticosteroid1.4%Prednisone100%Part D≥14 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
New England Journal of Medicine
2026 - Prognostic impact of tricuspid regurgitation improvement after transcatheter mitral valve replacement: results from an international multicentre registry
European Heart Journal - Valvular and Structural Heart Disease
2026 - Clinical Outcomes of Transfemoral Transcatheter Mitral Valve Replacement: Results from the CHOICE-MI Registry
JACC: Cardiovascular Interventions
2026 - Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial
Journal of the American Heart Association
2026
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”